Today Worcester Polytechnic Institute (WPI) announced that Abbott Laboratories, New York-based Bristol-Myers Squibb, and Shire Human Genetic Therapies of Cambridge, MA, will be inaugural partners of the school’s Biomanufacturing Education and Training Center, which is under construction. The facility, which is partially funded by a Massachusetts Life Sciences Center grant, is expected to be ready in late 2012 and will be a biomanufacturing pilot plant that provides training and education for those developing drugs and researching compounds using engineered living cells.
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
View all posts by Erin Kutz
